Patents by Inventor James M. Coull

James M. Coull has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040102571
    Abstract: This invention pertains to solubility enhanced polymers and methods, kits and compositions which enhance the aqueous solubility of said polymers. One set of preferred methods, kits and compositions embody or utilize phosphorous containing synthons and are most useful for modulating the solubility of synthetic nucleic acids and synthetic nucleic acid analogs. A second set of preferred methods, kits and compositions are most useful for modulating the aqueous solubility of peptides, other polyamides and most preferably peptide nucleic acid (PNA) polymers.
    Type: Application
    Filed: November 30, 2001
    Publication date: May 27, 2004
    Inventors: Brian D. Gildea, James M. Coull
  • Publication number: 20030232327
    Abstract: This invention is directed to methods, kits and compositions pertaining to PNA Molecular Beacons. PNA Molecular Beacons comprise self-complementary arm segments and flexible linkages that promote intramolecular or intermolecular interactions. In the absence of a target sequence, PNA Molecular Beacons facilitate efficient energy transfer between the linked donor and acceptor moieties of the probe. Upon hybridization of the probe to a target sequence, there is a measurable change in at least one property of at least one donor or acceptor moiety of the probe which can be used to detect, identify or quantitate the target sequence in a sample.
    Type: Application
    Filed: February 28, 2003
    Publication date: December 18, 2003
    Inventors: James M. Coull, Brian D. Gildea, Jens J. Hyldig-Nielsen
  • Patent number: 6664045
    Abstract: This invention is related to novel PNA probes, probe sets, methods and kits pertaining to the detection of microorganisms. The probes, probe sets, methods and kits of this invention can be used to detect, identify or quantitate one or more organisms in a sample wherein the organisms are selected from the group consisting of E. coli, Staphylococcus aureus, Pseudomonas aeruginosa, Pseudomonas cepatia, Pseudomonas fluorescens or organisms of a bacterial genus including the Salmonella genus, Bacillus genus or Pseudomonas genus. The preferred probing nucleobase sequence of the PNA probes used to detect the bacteria listed above are TCA-ATG-AGC-AAA-GGT (E.
    Type: Grant
    Filed: June 18, 1999
    Date of Patent: December 16, 2003
    Assignee: Boston Probes, Inc.
    Inventors: Jens J. Hyldig-Nielsen, James M. Coull
  • Patent number: 6649349
    Abstract: This invention is directed to methods, kits and compositions pertaining to Linear Beacons. In the absence of a target sequence, Linear Beacons facilitate efficient energy transfer between the donor and acceptor moieties linked to opposite ends of the probe. Upon hybridization of the probe to a target sequence, there is a measurable change in at least one property of at least one donor or acceptor moiety of the probe which can be used to detect, identify or quantitate the target sequence in a sample.
    Type: Grant
    Filed: September 10, 2001
    Date of Patent: November 18, 2003
    Assignee: Boston Probes, Inc.
    Inventors: Brian D. Gildea, James M. Coull, Jens J. Hyldig-Nielsen
  • Patent number: 6607889
    Abstract: This invention is directed to methods, kits and compositions which utilize Detection Complexes to detect or identify the presence, absence or quantity of a target molecule in a sample of interest. A Detection Complex comprises at least two component polymers and at least one set of donor and acceptor moieties. To each of at least two component polymers is linked at least one moiety of a set of donor and acceptor moieties, such that formation of the complex facilitates transfer of energy between donor and acceptor moieties of each set in a manner which, in an assay, produces changes in detectable signal which can be correlated with the presence absence of quantity of target sequence and/or target molecule of interest in the sample.
    Type: Grant
    Filed: May 29, 2001
    Date of Patent: August 19, 2003
    Assignee: Boston Probes, Inc.
    Inventors: James M. Coull, Brian D. Gildea, Jens J. Hyldig-Nielsen
  • Publication number: 20030124521
    Abstract: This invention relates to methods, kits and compositions suitable for the improved detection, analysis and quantitation of nucleic acid target sequences using probe based hybridization assays. The invention is more specifically directed to methods, kits and compositions suitable for suppressing the binding of detectable nucleic acid probes or detectable PNA probes to non-target nucleic acid sequences in an assay for a target nucleic acid sequence to thereby improve the reliability, sensitivity and specificity of the assay. The methods, kits and compositions of this invention are particularly well suited to the detection and analysis of nucleic acid point mutations.
    Type: Application
    Filed: May 5, 2000
    Publication date: July 3, 2003
    Inventors: James M. Coull, Jens J. Hyldig-Nielsen, Sven E. Godtfredsen, Mark J. Fiandaca, Kyriaki Stefano
  • Publication number: 20030105286
    Abstract: Novel peptide nucleic acids are disclosed which comprise nucleobases including C-pyrimidines and iso-pyrimidines. Suitable C-pyrimidines include pseudo-isocytosine and pseudo-uracil. Suitable iso-pyrimidine bases include iso-cytosine. Such compositions typically exhibit increased binding affinity.
    Type: Application
    Filed: July 1, 2002
    Publication date: June 5, 2003
    Inventors: Michael Egholm, Peter Nielsen, Ole Buchardt, D. Buchardt, Kim L. Dueholm, Leif Christensen, James M. Coull, John Kiely, Michael Griffith
  • Publication number: 20030091988
    Abstract: This invention pertains to methods, kits and compositions suitable for the detection, identification and/or quantitation of nucleic acids which are electrostatically immobilized to matrices using non-nucleotide probes which sequence specifically hybridize to one or more target sequences of the nucleic acid but do not otherwise substantially interact with the matrix. Once the nucleic acid is immobilized, the detectable non-nucleotide probe/target sequence complex, formed before or after the immobilization of the nucleic acid, can be detected, identified or quantitated under a wide range of assay conditions as a means to detect, identify or quantitate the target sequence in the sample. Because it is reversibly bound, the non-nucleotide probe/target sequence can optionally be removed from the matrix for detecting, identifying or quantitating the target sequence in the sample.
    Type: Application
    Filed: May 31, 2002
    Publication date: May 15, 2003
    Inventors: Jack T. Johansen, Jens J. Hyldig-Nielsen, Mark J. Fiandaca, James M. Coull
  • Publication number: 20030077608
    Abstract: This invention pertains to the field of combination oligomers, including the block synthesis of combination oligomers in the absence of a template, as well as related methods, kits, libraries and other compositions.
    Type: Application
    Filed: March 9, 2002
    Publication date: April 24, 2003
    Inventors: James M. Coull, Mark J. Fiandaca, Mark D. Kristjanson, Jens J. Hyldig-Nielsen, Theresa S. Creasey
  • Publication number: 20030073106
    Abstract: This invention pertains to methods, kits and compositions suitable for the detection, identification and/or quantitation of nucleic acids which are electrostatically immobilized to matrices using non-nucleotide probes which sequence specifically hybridize to one or more target sequences of the nucleic acid but do not otherwise substantially interact with the matrix. Once the nucleic acid is immobilized, the detectable non-nucleotide probe/target sequence complex, formed before or after the immobilization of the nucleic acid, can be detected, identified or quantitated under a wide range of assay conditions as a means to detect, identify or quantitate the target sequence in the sample. Because it is reversibly bound, the non-nucleotide probe/target sequence can optionally be removed from the matrix for detecting, identifying or quantitating the target sequence in the sample.
    Type: Application
    Filed: May 31, 2002
    Publication date: April 17, 2003
    Inventors: Jack T. Johansen, James M. Coull
  • Patent number: 6528267
    Abstract: This invention is directed to methods, kits and compositions pertaining to PNA Molecular Beacons. PNA Molecular Beacons comprise self-complementary arm segments and flexible linkages which promote intramolecular or intermolecular interactions. In the absence of a target sequence, PNA Molecular Beacons facilitate efficient energy transfer between the linked donor and acceptor moieties of the probe. Upon hybridization of the probe to a target sequence, there is a measurable change in at least one property of at least one donor or acceptor moiety of the probe which can be used to detect, identify or quantitate the target sequence in a sample.
    Type: Grant
    Filed: June 22, 2001
    Date of Patent: March 4, 2003
    Assignee: Boston Probes, Inc.
    Inventors: James M. Coull, Brian D. Gildea, Jens J. Hyldig-Nielsen
  • Publication number: 20030036059
    Abstract: This invention is directed to methods, kits and compositions pertaining to PNA Molecular Beacons. PNA Molecular Beacons comprise self-complementary arm segments and flexible linkages which promote intramolecular or intermolecular interactions. In the absence of a target sequence, PNA Molecular Beacons facilitate efficient energy transfer between the linked donor and acceptor moieties of the probe. Upon hybridization of the probe to a target sequence, there is a measurable change in at least one property of at least one donor or acceptor moiety of the probe which can be used to detect, identify or quantitate the target sequence in a sample.
    Type: Application
    Filed: June 22, 2001
    Publication date: February 20, 2003
    Inventors: James M. Coull, Brian D. Gildea, Jens J. Hyldig-Nielsen
  • Patent number: 6485901
    Abstract: This invention is directed to methods, kits and compositions pertaining to Linear Beacons. In the absence of a target sequence, Linear Beacons facilitate efficient energy transfer between the donor and acceptor moieties linked to opposite ends of the probe. Upon hybridization of the probe to a target sequence, there is a measurable change in at least one property of at least one donor or acceptor moiety of the probe which can be used to detect, identify or quantitate the target sequence in a sample.
    Type: Grant
    Filed: October 26, 1998
    Date of Patent: November 26, 2002
    Assignee: Boston Probes, Inc.
    Inventors: Brian D. Gildea, James M. Coull, Jens J. Hyldig-Nielsen, Mark J. Fiandaca
  • Publication number: 20020142326
    Abstract: This invention is directed to methods and compositions for sorting and/or determining microscopic organisms or cells. The methods and compositions are directed to the use of molecular probes to selectively stain the organisms or cells in combination with the use of binding partners to selectively immobilize the stained organisms or cells to a solid carrier. By combining the selectivity of both molecular probes and binding partners in an orthogonal method for staining and immobilization, these methods and compositions increase both the discriminating power of the assays and/or the certainty of the result obtained therefrom.
    Type: Application
    Filed: November 29, 2001
    Publication date: October 3, 2002
    Inventors: James M. Coull, Henrik Stender, Brian D. Gildea
  • Patent number: 6451968
    Abstract: Novel peptide nucleic acids and novel linked peptide nucleic acids, form triple stranded structures with nucleic acids. The peptide nucleic acids include ligands such as naturally occurring nucleobases attached to a peptide backbone through a suitable linker. Other nucleobases including C-pyrimidines and iso-pyrimidines can be used as the ligands in Hoogsteen strands to increase binding affinity. Two peptide nucleic acid strands are joined together with a linker to form a bis-peptide nucleic acid. The individual strands of the peptide nucleic acids in the bis compounds can be orientated either parallel or antiparallel to each other.
    Type: Grant
    Filed: July 15, 1994
    Date of Patent: September 17, 2002
    Assignees: ISIS Pharmaceuticals, Inc., Perseptive Biosystems, Inc.
    Inventors: Michael Egholm, Peter Nielsen, Ole Buchardt, Kim L. Dueholm, Leif Christensen, James M. Coull, John Kiely, Michael Griffith
  • Patent number: 6441152
    Abstract: This invention pertains to methods, kits and compositions suitable for the detection, identification and/or quantitation of nucleic acids which are electrostatically immobilized to matrices using non-nucleotide probes which sequence specifically hybridize to one or more target sequences of the nucleic acid but do not otherwise substantially interact with the matrix. Once the nucleic acid is immobilized, the detectable non-nucleotide probe/target sequence complex, formed before or after the immobilization of the nucleic acid, can be detected, identified or quantitated under a wide range of assay conditions as a means to detect, identify or quantitate the target sequence in the sample. Because it is reversibly bound, the non-nucleotide probe/target sequence can optionally be removed from the matrix for detecting, identifying or quantitating the target sequence in the sample.
    Type: Grant
    Filed: December 8, 1999
    Date of Patent: August 27, 2002
    Assignee: Boston Probes, Inc.
    Inventors: Jack T. Johansen, Jens J. Hyldig-Nielsen, Mark J. Fiandaca, James M. Coull
  • Patent number: 6441130
    Abstract: Novel peptide nucleic acids and novel linked peptide nucleic acids, form triple stranded structures with nucleic acids. The peptide nucleic acids include ligands such as naturally occurring nucleobases attached to the peptide backbone through a suitable linker. Other nucleobases including C-pyrimidines and iso-pyrimidines can be used as the ligands in Hoogsteen strands to increase binding affinity. Two peptide nucleic acid strands are joined together with a linker to form a bis-peptide nucleic acid. The individual strands of the peptide nucleic acids in the bis compounds can be oriented either parallel or antiparallel to each other.
    Type: Grant
    Filed: June 28, 1998
    Date of Patent: August 27, 2002
    Assignees: ISIS Pharmaceuticals, Inc., PepSeptive Biosystems, Inc.
    Inventors: Michael Egholm, Peter Nielsen, Ole Buchardt, Kim L. Dueholm, Leif Christensen, James M. Coull, John Kiely, Michael Griffith
  • Publication number: 20020064772
    Abstract: This invention is directed to methods, kits and compositions pertaining to Linear Beacons. In the absence of a target sequence, Linear Beacons facilitate efficient energy transfer between the donor and acceptor moieties linked to opposite ends of the probe. Upon hybridization of the probe to a target sequence, there is a measurable change in at least one property of at least one donor or acceptor moiety of the probe which can be used to detect, identify or quantitate the target sequence in a sample.
    Type: Application
    Filed: September 10, 2001
    Publication date: May 30, 2002
    Inventors: Brian D. Gildea, James M. Coull, Jens J. Hyldig-Nielsen
  • Publication number: 20020058278
    Abstract: The present invention relates to methods, kits and compositions suitable for the improved detection, quantitation and analysis of nucleic acid target sequences using probe-based hybridization assays.
    Type: Application
    Filed: September 10, 2001
    Publication date: May 16, 2002
    Applicant: Boston Probes, Inc.
    Inventors: Kyriaki Stefano, James M. Coull, Henrik Stender, Jens J. Hyldig-Nielsen, Kenneth H. Peterson
  • Patent number: 6361942
    Abstract: This invention is directed to methods, kits and compositions which utilize Detection Complexes to detect or identify the presence, absence or quantity of a target molecule in a sample of interest. A Detection Complex comprises at least two component polymers and at least one set of donor and accepter moieties. To each of at least two component polymers is linked at least one moiety of a set of donor and accepter moieties, such that formation of the complex facilitates transfer of energy between donor and acceptor moieties of each set in a manner which, in an assay, produces changes in detectable signal which can be correlated with the presence absence of quantity of target sequence and/or target molecule of interest in the sample.
    Type: Grant
    Filed: March 24, 1999
    Date of Patent: March 26, 2002
    Assignee: Boston Probes, Inc.
    Inventors: James M. Coull, Brian D. Gildea, Jens J. Hyldig-Nielsen